?1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E ?4 allele carriers
- 1 July 1997
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 42 (1) , 115-117
- https://doi.org/10.1002/ana.410420118
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Apolipoprotein E and α1‐antichymotrypsin polymorphism in Alzheimer's diseaseAnnals of Neurology, 1996
- No Genetic Effect of α1-Antichymotrypsin in Alzheimer DiseaseGenomics, 1996
- A4POE*4-associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphismNature Genetics, 1995
- Apolipoprotein E4 allele in a population–based study of early–onset Alzheimer's diseaseNature Genetics, 1994
- Genetic associations with human longevity at the APOE and ACE lociNature Genetics, 1994
- Apolipoprotein E genotype and Alzheimer's diseaseThe Lancet, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's diseaseNeurology, 1993
- Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- The prevalence of dementia: A quantitative integration of the literatureActa Psychiatrica Scandinavica, 1987